Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

Selection of the right drug for the right patient is a promising approach to increase clinical benefit of targeted therapy with monoclonal antibodies (mAbs). Assessment of in vivo biodistribution and tumor targeting of mAbs to predict toxicity and efficacy is expected to guide individualized treatme...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Pharmacol
Main Authors: Jauw, Yvonne W. S., Menke-van der Houven van Oordt, C. Willemien, Hoekstra, Otto S., Hendrikse, N. Harry, Vugts, Danielle J., Zijlstra, Josée M., Huisman, Marc C., van Dongen, Guus A. M. S.
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2016
Fag:
Pharmacology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877495/
https://ncbi.nlm.nih.gov/pubmed/27252651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00131
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker